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ABSTRACT
Descriptive Epidemiology of HIV Risk Factors Among Men: Chad Vs Cameroon.
By
Bonheur Dounebaine, MD, MPH (c)
April 26th 2017
Introduction
HIV remains a severe global health problem. The Republic of Chad is moderately affected
(1.3%), compared to Cameroon who suffers more of the burden of the HIV/AIDS (4.5%).
We described the HIV risk factors in two neighboring Central African Republics, and
compared the gaps in both countries.
Methods
This was a retrospective cross-sectional study; data was obtained from the Demographic
and Health Survey. A stratified multi-stage cluster sample design was conducted. The
sample size was 5248 in Chad and 7191 in Cameroon. We used SAS to fit a multilevel
logistic model, and conducted a multivariate analysis.
Results
The median age of respondents was 30 (IQR, 20-40) years in Chad, and 28 (IQR, 20-40)
in Cameroon. Only 12.45% reported had ever been tested for HIV in Chad, (41.77% in
Cameroon). In Chad, 46.40% of participants did not know a place to get HIV test, (11.15%
in Cameroon). The median number of lifetime sexual partners was 2 (IQR, 1-4) in Chad,
and 6 (IQR, 3-15) in Cameroon. Among Chadian participants 31.63% had only one
lifetime sexual partner, (10.76% in Cameroon). In Chad 86.95% of participants reported
having no sex partner other than their spouse in the last 12 months; (57.3% in Cameroon).
Conclusion
Condom use and HIV testing rates were very low among Chadian men comparing to
Cameroonian men; however, Cameroonian men were more likely to engage in multiple
sexual partners and extra-marital relationship than Chadian men.
Keywords: HIV testing, HIV risk factors, Condom use, sexual partners, Chad, Cameroon;
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Chapter I.

Introduction

i.Background
The Human Immunodeficiency Virus (HIV) responsible for the Acquired ImmuneDeficiency Syndrome (AIDS) remains a severe global health problem; discovered more
than three decades ago, the HIV/AIDS has speedily entered the list of the deadliest
infections. Its high incidence and prevalence particularly in developing world, which is a
threat to the achievement of the Sustainable Development Goals (SDG), has led the
World Health Organization (WHO) and its partners to reconsider several times the proper
techniques and strategies to fight and control it. The report shows a decline in new
infections of 38% from 2001 (3.4 million) to 2013 (2.1 million) (1). However, the more
recent report showed that the incidence among adults aged 15 years and older has
remained steady with an estimate of 1.9 million new cases from 2010 to 2015 (2).
About two million children worldwide were living with HIV in 2011, and 370,000 were
infected during the same year (3); more than 90% of the mother to child transmission
were reported in sub-Saharan Africa where more than 90% of HIV infections in children
under the age of 15 are due to mother-to-child transmission (4). In June 2016, the United
Nations General Assembly (UNGA) has set an ambitious goal of ending AIDS by 2030.
According to the plan, three milestones should be reached by 2020: reduce global
incidence to less than 500000 cases, reduce mortality to less than 500000 deaths, and
eliminate HIV-related stigma and discrimination (2).
The Republic of Chad as other sub-Saharan African countries affected by this scourge,
though at a moderate level, is taking the same preventive approach. According to 2014
nationally representative survey, by the Demographic Health Survey (DHS) the national
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prevalence was 1.3 % (5). The first study that detected and reported the presence and
circulation of HIV in Chad was carried out in 1989; and found a seroprevalence rat e
varying from 0 to 1.1% (6). However, the peak of the epidemic was reached in 2002 with
a national seroprevalence of 3.4% among adults aged 15 years or older (7). In 2011, the
ministry of health set a challenging objective with different international partners, to
reduce the transmission of HIV from mother to her baby from 32% to 5% by the end of
2015 (8) and take other preventive measures. According to the UNAIDS 2016 estimates,
Chad is among the very few countries that have reversed the HIV incidence by more than
50% change in new HIV infections among adults (aged 15 years and older), from 2005 to
2015 (2).
Although significant effort has been made these recent years, the Republic of Chad is
yet to reach its targets; the health system is crippled by a deficit of medical staff, and lack
of real coordination at the central level. Nonetheless, the international partners have
played a major role in the coordination and support to the ministry of health (MOH).
On the other hand, the Republic of Cameroon has stronger health care system, and is
more equipped comparing to Chad, regarding health care facilities and qualified human
resources; but paradoxically suffers more of the burden of the HIV/AIDS. Indeed,
according to the UNAIDS report, the prevalence of HIV among adults aged 15 years and
older was 4.5% in 2015 (9). This prevalence reached a peak of 5.4 % in 2000 (10). Thus,
Cameroon has one of the highest HIV prevalence in Central Africa, despite its potential
to better carry out the fight against the disease. According to the UNAIDS 2016 estimates,
Cameroon is among the countries which have observed a 25–49% increase in the HIV
incidence among adults (aged 15 years and older), from 2005 to 2015 (2). So, are HIV
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risk factors more prominent among populations in Cameroon than those in Chad? This
is the question we will answer at the end of this study.
ii.Justification of the study
Whereas it is accepted that with targeted interventions, the risk of HIV can be significantly
reduced, the republics of Chad and Cameroon are still lagging behind, comparing to
countries like Senegal, or the Democratic Republic of Congo (DRC), despite huge
investment in the program. In Chad, this may be explained by the deficit of regular
monitoring and evaluation of the national HIV/AIDS program. However, also, very few or
no investigations are conducted by the domestic staffs to suggest an improvement in the
surveillance and preventive methods to the government. International institutions write
most reports; their data collections are mainly done in the cities. However, 80% of the
Chadian population lives in the rural area (11) where HIV surveillance system is weak.
The DHS dataset we used for this analysis was a nationally representative data collected
in all the regions and included rural and urban areas.
Finally, this study is an attempt to independently quantify the magnitude, and the
description of the risk factors associated with HIV distribution in two neighboring Central
African Republics, and to compare the gaps in both countries.
iii.Objectives
Main Objective:
To describe the distribution of the HIV risk factors in both Chad and Cameroon and make
an epidemiological comparison between the two nations.
Specific objectives:
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1.

To compare the proportion of voluntary screening among rural and urban areas in

both countries;
3.

To determine and compare the frequency of STDs in regions of both countries;

4.

To assess the magnitude of knowledge about HIV among populations in both

countries;
5. To assess the and compare the proportion of condom use in both countries;
6. To compare the number of sexual partners among populations in both countries;
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Chapter II: Literature Review

i. Countries presentation
The Republics of Chad and Cameroon are two neighboring countries in Central Africa,
Cameroon is in the South-West of Chad. The North-East of Cameroon and South-West
regions of Chad have much in common; some parts of these areas have similar
geographic and demographic distribution with same ethnic groups across the two
countries. However, the rest of the countries are very different, and there is enormous
diversity in each country.
The Republic of Chad is a landlocked territory located between the 7 0 and 240

North

latitude and 130 and 240 East longitude, with an area of 1 284 000 km2 and an estimated
population of 12 448 175 (12). According to the general census, 57% of the population
has less than 18 years old, and 50.7 % are female; geographically speaking 47% of
Chadians live in the 10% of the Southern part (13).
Since 1988, Chad has adopted the district based health system; the ministry of health
skeleton has three pyramidal levels. The first or central level which comprises the general
and technic directions (in the Ministry of health); the second or intermediary level, makes
up of health delegations (with regional hospitals); and the third or peripheral level includes
health districts ( with district hospitals), and health areas (with primary care centers).
Therefore, administratively, the Republic of Chad is divided into 23 regions (with health
delegation in each region); which comprise 77 official health districts and around 773
functional primary health centers (14). As the rest of the governmental sectors in Chad,
the ministry of health is crippled by long-term corruption, and as a result, the populations
is faced with multiple infectious diseases outbreaks every year, and high rate of infant
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and maternal mortality. According to the UNDP human development index 2015 report,
Chad is classified 185 over 188 (15).
Cameroon is in on central African coast and shares borders with Gabon, Congo, and
Equatorial Guinea on the South, with Nigeria on the West, with the Central African
Republic on the East, and with Chad in the North borders. Cameroon has a land mass
area of 475,000 km2 and a projected population of about 23,924,000 in 2016 (16); it is
divided into ten administrative regions which are then organized into 58 districts, 360 subdistricts, and 339 councils; the health system has three levels as similar in Chad: the
central, intermediate and peripheral level (17). According to the UNDP report on human
development index, Cameroon is classified 153rd over 188 (15)

ii.History of HIV in Chad and Cameroon

The history of HIV/AIDS goes back to the late 20 th century with probably several decades
of silent period when the disease was unknown or unreported until June 5, 1981 when
the Centers for Disease Control and Prevention (CDC) published in their Morbidity and
Mortality Weekly Report (MMWR), cases of immune system deficiencies associated with
rare lung infection, Pneumocystis carinii pneumonia (PCP), in Los Angeles (18). On
September 24, the term “AIDS” (acquired immune deficiency syndrome) was used by
CDC for the first time, and they released the first case definition of AIDS: “a disease at
least moderately predictive of a defect in cell-mediated immunity, occurring in a person
with no known cause for diminished resistance to that disease.”(19)
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On May 20, 1983, Professor Luc Montagnier, of the Pasteur Institute in France and his
team reported for the first time the isolation of a retrovirus named Lymphadenopathy
Associated Virus (LAV), probably the etiology of AIDS (20). Later that same year, in
November 1983, Dr. Robert Gallo’s lab at the National Institute of Health in the United
States (US) grew the AIDS virus in immune system cells; and the next year, on April 23,
1984, it was announced that Dr. Robert Gallo and his colleagues had discovered the
cause of AIDS, the retrovirus Human T-cell Lymphotropic Virus-3 (HTLV3)(21). In June
1984, Dr. Robert Gallo and Professor Luc Montagnier held a joint press conference and
announced that LAV and HTLV3 are almost certainly identical and are the likely cause of
AIDS.
On January 11, 1985, the CDC revised the AIDS case definition to note that AIDS is
caused by a newly identified virus and issued provisional guidelines for blood screening
(22). In May 1986, the International Committee on the Taxonomy of Viruses declared that
the pathogen agent responsible for AIDS would officially be known as Human
Immunodeficiency Virus (HIV). Moreover, Pr Montagnier will be awarded later the Nobel
Prize in Medicine for its discovery. In February 1987, the World Health Organization
(WHO) launched The Global Program on AIDS to raise awareness, to initiate research,
and to formulate policies. That same year, the Food and Drug Administration (FDA) in the
US approved the first antiretroviral drug, zidovudine (AZT), and the Western Blot blood
test kit, a more specific test for HIV antibodies (23). In October 1987, AIDS became the
first disease ever of main concern at the United Nations (UN) General Assembly. The
General Assembly decided to mobilize the entire UN system in the struggle against AIDS
worldwide and the WHO was assigned to be the leader.
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In 1988, the WHO declared December 1st to be the first World AIDS Day. The same year,
the UNAIDS reported that women are more affected by HIV/AIDS in sub-Saharan Africa
than men.
In the Republic of Chad, several investigations were conducted in the late eighties in
different regions with the aim of detecting the presence of circulation of the HIV. However,
none of the reports revealed the presence of the HIV infection among populations (24,
25, 26, 27, 28). The first investigation to reveal the presence of HIV in Chad was carried
out by Louis et al. (29) in 1989 and reported a prevalence varying among regions from 0
to 1.1%, the southern parts sharing border with Cameroon were the most affected; the
report showed no presence of HIV in the Northern regions. Since then the epidemic has
perniciously evolved to reach a peak in 2002 with a national prevalence of 3.4% among
adults aged 15 years or older (7).
There were only seven infectious diseases surveillance sites in Chad in 1999; however,
with the introduction of HIV in the regions, the ministry of health supported by partners
has improved the monitoring system, by 2003 there were 17 surveillance sites in the
countries; which has improved the report. Alarmed by the reports, the health authorities
took following actions. First, the national prevention of mother-to- child transmission
(PMTCT) of HIV program was established in 2002. In 2005, the national prevalence of
3.3%(30) was estimated. Consequently, the report showed a decline in the prevalence of
HIV among pregnant Chadian women from 5% in 2002 to 3.1% in 2010(31).
Different programs and groups played important roles in the fight against HIV/AIDS in
Chad. Within the ministry of health, the national program of combating HIV (Programme
National de Lutte Contre le VIH or PNLV), this program is managed by National staffs
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and supported by partners such as the WHO, UNFPA, and UNICEF. The program
oversees elaborating the national protocol and guidelines usually based on the
WHO/UNAIDS recommendations. Nonetheless, the obstacles that faced the team is the
lack of financial and qualified human resources to conduct regular monitoring and
evaluation of the program, the implementation of activities in some regions, and regular
surveillance in the regions.
In Cameroon, the first case of HIV has been reported in 1986 (32). As in Chad, the
infection was rampant and little was done effectively to stop its progression at that early
stage. However, unlike its neighbor Chad, the Cameroonian health system was better in
place to fight the epidemic. The level of education is higher among Cameroonian
population comparing to Chadian. Moreover, the critical lack of qualified national staffs
that can conduct monitoring/evaluation as mentioned in Chad may not be observed in
Cameroon at the same level. However, the HIV infection scaled up quickly among the
Cameroonian populations. The epidemic is disproportionately distributed among regions.
The antenatal care PMTCT (ANC/PMTCT) was established in 2000 to impact the
incidence of the infection. In 2004, the Men as Partners (MAP) (33) program was initiated
to improve men participation in the PMTCT program. Similarly, to the organization in
Chad, the Cameroonian Ministry of health has established the National AIDS Control
Committee (NACC) that monitor the progress of infection in the regions, and implement
protocols.
On January 28, 2003, President George W. Bush created the U. S President’s Emergency
Plan For AIDS Relief (PEPFAR). That same year on March 31, the Bill and Melinda Gates
Foundation awarded 60 million US dollars as a grant to the International Partnership for
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Microbicides to support research and development to prevent transmission of HIV. In
Cameroon the PEPFAR program began in 2009-2010, the PEPFAR initiative is
administered by CDC and UNAIDS, and aligns with the Cameroonian HIV/AIDS strategic
plan in the areas of PMTCT; HIV counseling, screening and testing; prevention of sexual
HIV transmission; blood safety; HIV care and support; and laboratory strengthening (34).
The Republic of Chad does not benefit from the PEPFAR program; the main external
support comes from the WHO, UNFPA, and UNICEF.
One of the fact to be acknowledged is that the U.S institutions have played a major role
in the history and evolution of the HIV/AIDS more than all the rest of the countries
combined. Relatively recent inventions, protocols, or pharmaceutical products made in
the U.S have shaped the future of the pandemic. On May 7, 1993, the FDA approved the
female condom; that same year, on December 18, the CDC expanded the case definition
of AIDS, declaring that those with CD4 counts below 200 to have AIDS (35). In that same
MMWR, CDC added three new conditions: pulmonary tuberculosis, recurrent pneumonia,
and invasive cervical cancer to the list of clinical indicators of AIDS. In 1995 Saquinavir
the first protease enzyme inhibitor was approved by the FDA. This has revolutionized a
new era of highly active antiretroviral therapy (HAART) (36).
In 1996, several improvements were approved by the FDA including the first HIV home
testing and collection kit, the viral load test, the first non-nucleoside reverse transcriptase
inhibitor (NNRTI) drug, Nevirapine (NVP) and the first HIV urine test. In 1997, on
September 26, Combivir, a combination of two antiretroviral drugs in one tablet was
approved (36). The CDC reported the first substantial decline in AIDS deaths in the United
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States largely credited using HAART. However, the UNAIDS estimated that year that 30
million people were infected worldwide (37).
In 1999, the WHO estimated that 33 million people were living with HIV worldwide, 14
million have died of AIDS; thus, the HIV/AIDS has become the fourth biggest killer
worldwide and the number one killer in Africa (38). Later that year the CDC released a
new HIV case definition to help expand the surveillance efforts and to more accurately
track the changing course of the epidemic (39).
In September 2000 within the Millennium Declaration, the United Nations adopted the
Millennium Development Goals (MDG), which included a specific goal of reversing the
spread of HIV/AIDS, malaria, and TB. In July 2002, UNAIDS reported that HIV is the new
leading cause of death by far in sub-Saharan Africa and the number four biggest global
killer. Average life expectancy in sub-Saharan Africa fell from 62 years to 47 years
because of AIDS. During that year, approximately 3.5 million new infections occurred in
sub-Saharan Africa, and the epidemic claimed the lives of about 2.4 million people in
Africa (40).
On June 10, 2004, leaders of the “Group of Eight” (G8) Summit called for the creation of
a “Global HIV Vaccine Enterprise,” a consortium of government and private-sector parties
assigned the coordination and research to find an effective HIV vaccine. However, up to
now, the HIV vaccine is yet to be approved although several laboratories are working on
it at different levels of clinical trial. Although, the treatment has tremendously improved
with HAART and the life expectancy for people receiving ART now approaches normal
life expectancy in some countries (41). However, despite this progress HIV/AIDS remains
among the biggest killers in sub-Saharan Africa.
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iii.Epidemiology of HIV in Chad and Cameroon

Globally, it is estimated that 35 million people were living with HIV at the end of 2013 (1).
From the very beginning of the reported cases to the present, approximately 79 million
people were infected with HIV, and 39 million died worldwide. However, the pandemic is
inequitably distributed across demographics and regions; sub-Saharan Africa bears the
heaviest burden. Indeed, 71% of people living with HIV (PLHIV) are in Africa (42). The
high-burden countries are Southern African countries (43).
Women are the most affected; it is estimated that of the global 35 million PLHIV, 16 million
are women, and 80% of them live in sub-Saharan Africa (1). Most recent data from
countries surveillance system show prevalence among women of reproductive age
attending antenatal care service (ANC) of 41.1% in Swaziland, 30.4% in Botswana,
29.5% in South Africa, 24.3% in Lesotho, and 18.8% in Namibia; however, the prevalence
is lower in some countries, less than 1% of ANC attendees in Senegal, Mauritius or Eritrea
(43).
In Chad, although the national prevalence is relatively lower (comparing to its neighbor
Cameroon), HIV is a big concern in large cities and among women. The epidemiology of
HIV/AIDS in Chad was insidious within the first decade of its introduction because no
serious measure was taken by the authorities to counteract its spread. Most of the actions
were undertaken by non-governmental organizations (NGOs) to inform the populations
about the disease, its mode of transmission, and measures of protection. The emphasis
was on education and sexual behavior change. Young people were trained to educate
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their fellows about the use of condoms in the communities, in high schools and colleges,
but mainly in large cities, because HIV was still unknown and remained taboo in many
regions of Chad.
HIV is disproportionately distributed among Chadian regions; the Southern regions bear
the highest burden, this is probably due to the proximity with Cameroon and the Republic
of Central African where HIV prevalences are higher (respectively 4.5% and 3.7%) than
in Chadian regions (9).
In 2005 the national survey (44) estimated the prevalence at 3.3% at national level.
However, the report showed the prevalence in the urban areas of 7% and 2.3% in the
countryside. According to that survey, the capital city (N'djamena) had the second highest
HIV prevalence in the country (8.3%) following the region of Logone Occidental (9.8%).
Nonetheless, from 2005 to 2015, there was a progressive decline in the incidence of HIV
in Chad due to communities’ mobilization, mass campaign awareness, and programs
focusing on behavior change. The national survey conducted in 2014 showed a
prevalence of 1.3% (5).
In Cameroon, HIV/AIDS is among the top public health priorities, according to the recent
estimations and surveys, the prevalence was 4.5% in 2015 (9) among adults aged 15
years and older and 620000 PLHIV. This was the second highest HIV prevalence in
Central Africa in 2015, following its neighbor country, the Equatorial Guinea with a
prevalence of 4.9% among adults 15 and older (9). However, as in Chad, HIV is unevenly
distributed, the prevalence decreases from the Northern regions (with 1,2% in extreme
North to 5.5% in Adamawa) to the Southern regions (with 5.7% in South West, to 7.2%
in South region) (45). Women bear the highest burden, according to the national survey
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carried out among pregnant women in 2009 (7.6%) and 2012 (7.8%), HIV was,
unfortunately on rising among this group (45) and again women living in the Southern
regions were the most concerned (with prevalence reaching 9.5% in South region and
11.9% in central region).

As in Chad HIV transmission in Cameroon in mainly

heterosexual (46), and the mother to child transmission rate is high in both countries, the
estimated rate was 17% in 2013 according to the WHO report (47). However, a
respondent-driven sampling survey carried out by Park JN et al. among a group of MSM
in Yaoundé and Douala the two biggest cities in Cameroon, showed high HIV prevalence
of 47.3% (98/207) and 28.6% (73/255) respectively (48).

iv.HIV risk factors in Chad and Cameroon

To effectively prevent HIV infection, the WHO promote key components of health
intervention and behavior change in the communities, which consist of combination of
approaches including reduction of number of sexual partners, correct and consistent use
of condoms, delaying in sexual debut, HIV testing and counseling, treatment for STIs and
circumcision (49).
Although Men are known to be more frequently involved in risky behavior comparing to
women in sub-Saharan Africa, they, however, fall less victim to HIV. In Cameroon, as in
Chad sexual behavior varies from one region to another, and there is sometimes
enormous discrepancy due to cultural, educational, and religious factors. Premarital sex
is still viewed as a break with tradition, but the reality is that it is more and more acceptable
and less relevant among the new generation.
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In Cameroon, a study showed that the percentage of sexually active adolescents before
marriage varies from 8% in the Northern regions to 69% in the Central and Southern parts
(50); new data might even surmount these statistics. According to the 2004 national
demographic health survey, the mean age of first sexual intercourse was 16.5 years (51)
and, a study carried out by N. Lydié et al. (52) in the capital city, Yaounde found that the
median age at first sexual intercourse was 16 for men and 17 for women; in addition,
55.7% of the men had had two or more partners in the last 12 months, whereas 66·3% of
the women had had only one partner. More recent survey conducted among 2660 high
school students aged 16-19 years old in Yaounde showed 64.3% had their first
heterosexual contact when they were between 10 and 16 years old, the mean age at the
first sexual debut was 15.3 years; and 43.6% of the sexually active participants had at
least two partners (53).
In Chad also, the average age at first sexual intercourse is low, 15.9 years for boys and
18.9 years for girls (54) according to a recent survey by Rwenge JRM et al. (54), 10.7 %
of males and 19% of girls aged 15-19 years and 9.7% of boys and 35,5% of girls aged
20-24 years in Chad have experienced their first sexual intercourse, whereas in
Cameroon these statistics were respectively 11.5% and 18% for boys and girls aged 1519 years old, and 10.7% and 21.6% for males and girls aged 20-24 years.
Although, studies showed that married adolescents girls in sub-Saharan Africa are
particularly at higher risk of HIV comparing to girls that completed their adolescence prior
to marriage (55), surveys in some countries including Cameroon has contradicted this
result (56, 57), concluding that girls that get married at older age are at increased risk for
HIV because of longer period between first sexual intercourse and first marriage.
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A more recent study conducted among university students in Northern Cameroon
concluded that there were alarming risks of sexual behavior among this group, 80.3% of
the participants had exposure with pornographic viewing and was positively associated
with HIV risk; The frequency of premarital sex was 92.8 % with a significant male
predominance (58).
Generally, HIV risk is inversely associated SES. However, recent studies have
contradicted this finding among Cameroonian women, who despite their higher
educational level, and good standing in life have high HIV prevalence comparing to
women with a lower educational level (59). Despite their good knowledge about HIV
infection, this group of women reported engaging in the risky sexual behavior. Similar
observation was made among wealthy Cameroonian men who conversely with high SES
have high HIV prevalence because they are frequently involved in risky behaviors such
as non-regular sexual partners, increased exposure to STDs, increased concurrencies,
and lifetime sexual partners (60). Among both men and women of this group, there was
reported decreased condom use with other partners. A study conducted in Kenya has
revealed that wealthy women are more likely to engage in materialism, and therefore
asking frequently for an expensive gift such as cars, cell phones, or cash, which are
drivers of transactional sex (61). However, we did not come across in the literature if this
finding could be extrapolated to the Cameroonian population.
The national demographic health survey conducted in 2014 in Chad found that 0.7% of
Chadian women aged 15-49 years old were engaged in multiple sexual partnerships
within the last 12 months, however this proportion was found to be 3% among women
with higher educational level, the average number of lifetime sexual partners was 1.3 for
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women with less education and 1.8 for women with higher education (62). Among men
of 15-49 years old, 16% reported having multiple sexual partners in the last 12 months;
there was no significant difference between educational or SES levels (62).
Another HIV risk factor among populations in Chad and Cameroon frequently reported in
the literature is the infrequent use of a condom. A survey conducted among Cameroonian
students found 43.4% did not use a condom during the first sexual intercourse (58). A
recent study conducted in the region of Northwest revealed that 72% of 414 adolescents
that participated reported inconsistent condom use, 35% reported having used condom
at last sexual intercourse, and 56% reported having used condom at least once (63). A
similar survey conducted among high school students in Yaoundé showed 52.1% of the
sexually active adolescent girls used condoms, among them 41.5% used it occasionally,
and 6.4% had regular unprotected sex (53).
On the other hand, Chad is among the sub-Saharan countries with the lowest condom
use. According to the national survey in 2004, only respectively 9.5% and 3.5% of sexually
active boys and girls aged 15-19 years used a condom at their first sexual intercourse
(64). The more recent national survey, conducted in 2014-2015 reported that, among the
women aged 15-49 years old that had multiple sexual partners, 20% reported using a
condom, and condom use were significantly higher among women with tertiary education
(38.7%). However, among men aged 15-49 years old with multiple sexual partners, only
7.6% used a condom; nonetheless, condom use was significantly higher among men with
highest educational level (42.2%) and higher SES (25.7%) (62).
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Alcohol consumption is more and more being reported as positively associated with risk
of acquiring HIV infection because under the influence of alcoholic beverage consumers
are tempted to engage in unprotected sex irrespective of the partner profile ( 65). In
Cameroon, as in Chad, alcohol consumption is not uncommon, according to the WHO
report, about 41.4% of men and 25.8% of women consume alcohol regularly in Cameroon
(66). In Chad, according to 2014 WHO global status report on alcohol and health, 37.5%
of males aged 15 and older and 24.7% of females aged 15 and older consume alcohol
(67). Kongnyuy EJ et al. analyzed the Cameroon Demographic Health Survey (DHS
Cameroon) 2004, among the 2678 married men participants aged 15 to 59 years, 25.8%
reported taking alcohol before their last sexual intercourse and 21% indicated that their
last sexual intercourse was with a woman other than their wife or cohabiting partner (68).

v. HIV counseling and testing services in Chad and Cameroon

HIV testing and counseling is the single most important step for treatment and prevention.
The UNAIDS has set an ambitious goal for the control and prevention of the HIV
pandemic, one of the targets includes that 90% of PLHIV should know their HIV status by
2020 (69). The proportion of PLHIV that are aware of their status has increased globally
over the last decade; in sub-Saharan Africa, it was estimated that only 10% of people with
HIV knew their situation (70), however, in 2015 it was estimated that 55% of all individuals
with HIV in Africa and 60% of people with HIV globally knew their status (71). There is a
discrepancy between the proportion of men and women who had HIV test in Low and
Middle-income countries; report showed that about 70% of adult HIV tests done in 2014
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were conducted for women alone (72). This could be explicated by the increase in
maternal health activities and the incorporation of PMTCT care packet of the antenatal
care.
Despite the increase in HIV testing in sub-Saharan Africa where the burden of the disease
is even higher, many people still don’t know their status; and many of those who dare to
attend the voluntary and counseling test (VCT) do not return for their results, hence the
WHO estimates that less than 40% of PLHIV know their status (73). In Cameroon as well
as in Chad the testing rates are low. According to the CNLS (Comite National de Lutte
Contre le Sida), surveys conducted in Cameroon in 2008, showed that 40.8% of people
got tested for HIV, but this percentage declined gradually to 24.6% in 2009, and then with
an upward trend in 2012 reaching 41% (74). Moreover, another study revealed that 36%
of infected men and 30% of infected women never tested for HIV (75). In a retrospective
analysis of records in 6 district hospitals in Douala (second biggest city), Ngangue P et
al. found that among the 32,020 analyzed records, the failure to return rate was 14.3%
among people who had counseling and testing between January 2009 and December
2013 (76); reasons for not returning for their results were various including housewife
status or having a positive/undetermined/requiring confirmation result, and providerinitiated testing and counseling.
In Chad, the screening rate is among the lowest in central Africa; according to a national
survey in 2004, only 0.4% of women had HIV test and received their results, comparing
to 4% for men (64). A more recent survey carried out in 2014, revealed that 41% of
women knew where to get the HIV test, but only 14% got tested and received their results;
2% did not return for their results. However, the report showed that there was significant
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difference among educational level, with 73% of HIV testing among women with higher
education and only 8% of women with lower educational attainment got tested; significant
difference was also observed among different SES levels, 37%, and 7% respectively for
women of high and low SES (62). Among men, 51% knew where to get tested, but only
14% did the test and received their results; testing was higher among wealthier and
educated men (62).
Counseling and screening are the core step in the control and prevention HIV/AIDS. It is
the cornerstone that links people to care and enable them to initiate ART or induce
behavior change in the community. Since the approval of the rapid diagnostic test in the
1990s, the screening method for HIV has been simplified and expanded to the remote
areas around the world. However voluntary screening that allows people to know their
status is still a problem; according to the WHO, millions of people still ignore their positive
status and unwillingly continue to transmit the virus to their partners, some people are
aware of their positive serology too late when HAART could not improve their health. HIV
screening is also beneficial for individuals identified as HIV seronegative or
seroconcordant negative couples, as the counseling provides access to HIV prevention
services, including condoms, male circumcision and other awareness of the risk factors.
The main purpose of the national protocols should include maximum early tracking of
seropositive individuals in the community. To make the service of HIV screening test
easier and accessible, the WHO recommends the use of rapid diagnostic tests (RDT)
rather than the conventional laboratory-based diagnostics such as enzyme immunoassay
(EIA) (77). Although the WHO supports the mandatory HIV and other blood borne viruses
test prior to transfusion of blood, it clearly opposes the mandatory testing of people;
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therefore, the WHO recommends practitioners to adhere to the 5Cs: Consent,
Confidentiality, Counseling, Correct test results and Connections to treatment, care and
prevention services; which protect the human rights (78, 79).
To improve the overall HIV testing the WHO has recently introduced the new HIV selftesting (HIVST), a new initiative to help achieve the United Nations 90–90–90 targets
(80), and specifically the first target of diagnosing 90% of all people with HIV by 2020
(69). HIVST is intended to complement the already existing testing methods; in addition,
it aims at reaching more men, and adolescents in developing countries; the WHO also
recommend that “voluntary assisted partner notification services should be offered as part
of a comprehensive package of testing and care provided to people with HIV” (81).
The WHO acknowledges the need to give high priority to increased access to HIV
screening services for adolescents and to support approaches to improving adherence to
treatment and retention in care for adolescents living with HIV (ALHIV). It is necessary to
consider Post-test support particularly for teens, and standards for quality post-test
counseling are needed because the lack of linkages between testing, and subsequent
care discourages adolescents from seeking HIV testing in the first place (82).
Screening policies also target children and adolescents; in 2012, it was reported that 630
000 infants, children, and young adolescents below 15 years had been started on ART,
representing a 28% coverage rate among children in need of ART (83); once again it
can’t be stressed enough that screening was determinant. This coverage follows
increased emphasis on PMTCT programs that included early infant diagnosis and early
initiation of ART for infants. The main hindrances to HIV screening include stigma and
discrimination.
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HIV testing for newborns and infants less than two years is challenging, the presence of
maternal anti-HIV antibody makes it impossible to use standard RDT to diagnose infection
in HIV-exposed infants up to 18 months of age. However, more complex and costly
virologic tests such as nucleic acid testing (NAT) can be performed to detect the presence
of the virus itself (84).
In 1995, after perinatal transmission of HIV was proven to be substantially reduced by
administration of AZT to HIV seropositive pregnant women and their babies it was
recommended in the United States that all pregnant women be counseled and
encouraged to undergo voluntary testing for HIV (85, 86). The recommendation will be
gradually improved and expanded to the rest of world. It is reported that about 40% of
pregnant women in low- and middle-income countries were counseled and tested in 2012,
up from 26% in 2009 (87); The Republic of Chad has failed to make progress in that
matter too, indeed up to now there are no national HIV testing guidelines, but the Chadian
PMTCT program relies on the WHO HIV screening guidelines.
In Chad, there is low access to HIV test screening which is partially due to low ANC
coverage. However, the ministry of health recommends systematic proposition of HIV
counseling and testing to anybody accessing a medical service nationwide. However, this
recommendation is not observed in practice. Testing coverage among pregnant women
in Chad was 7% in 2012 it was the lowest coverage in the group of high burden countries
followed by Democratic Republic of Congo 9%, and Nigeria 19%; whereas countries like
Zambia, Mozambique, South Africa, and Botswana have respectively greater than 95%;
in addition, Chad has only 4% of early infant diagnosis which was the lowest coverage
(83).
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vi.HIV Management and PMTCT programs in Chad and Cameroon

HIV treatment is one of the key factors for the prevention and control of the epidemic
among the communities. Since the discovery of the first drug, significant efforts have been
made to improve the protocols, and new drugs with fewer side effects which have
tremendously improved patient’s adherence to treatment and care.
Since it was discovered that AZT could lower the risk of transmission of HIV from the
pregnant mother to its baby in 1995 (86), enormous effort has been made to treat infected
pregnant women and to prevent mother to child transmission of HIV. Indeed, it is known
that in the absence of any intervention the likelihood of vertical transmission of HIV is 1545% (5–10% during pregnancy, 10–20% during labor and delivery and 5–20% through
breastfeeding); antiretroviral (ARV) drugs can reduce this transmission to less than 5% in
breastfeeding and to less than 2% in non-breastfeeding (87, 88). However, in subSaharan Africa where 80% of HIV-seropositive women live (1), there are still many
obstacles such as stigma or discrimination that prevent the uptake of the PMTCT national
programs. In 2000 the first WHO recommendation for ARV drugs for PMTCT guidelines
(89) including short-course prophylaxis starting late in pregnancy or during labor, with
single-dose NVP for mothers and infants had changed considerably. These treatment
guidelines have been updated several times, in 2004, 2006, 2010 and recently the edition
of 2013(79) recommends early and immediate initiation of ART for pregnant women living
with HIV, serodiscordant couples, people with TB-HIV co-infection, people with hepatitis
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B-HIV co-infection, and children less than 5 years old living with HIV, irrespective of their
CD4 cell count.
For the PMTCT, these guidelines recommend two options: ‘’providing lifelong ART to all
pregnant and breastfeeding women living with HIV regardless of CD4 count or clinical
stage or providing ART for pregnant and breastfeeding women with HIV during the
mother-to-child transmission risk period and then continuing lifelong ART’’(79). Therefore,
the terms option A, B, and B+ are no longer used. To simplify the HIV management and
to improve adherence to treatment, the new WHO guidelines recommends a regimen of
TDF + 3TC or FTC + EFV, taken as single fixed-dose combination pill once daily, which
is safer and affordable (79). As countries shift toward TDF-based regimens, the use of a
fixed-dose combination of the single pill should continue to be given priority (90).
For the adults living with HIV the CD4 threshold for treatment of is being raised to 500
cells/mm3. The new guidelines for HIV treatment in adults, adolescents, and infants is
provided in the WHO 2016 recommendations (91).
Globally, the ART coverage for all people living with HIV reached an estimate of 41% (15
million people) in 2015 (92). Nonetheless, the developing world is lagging in term of ART
coverage.
The Republic of Chad is among the 21 priority African countries identified in the ‘’Global
Plan towards the elimination of new HIV infections among children by 2015 and keeping
their mothers alive’’ (93) these high-burden countries account for 90% of the pregnant
women living with HIV. Nonetheless, the report shows that there has been a decline from
26% in 2009 to 17% in 2012 of mother to child transmission (79).
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In 2011 in Chad, the reported number of people receiving ART was 32832 out of 100000
estimated eligible people, making 33% of the ART coverage. However, in 2012 the ART
coverage has increased to 40% (40856 people received ART out of 100000 estimated)
(83). For 20000 children, eligible for ART only 1531 (8%) received in 2011, but the
increase was significant in 2012 when over 20000 eligible children, 5842 (29%) received
it (83). For an estimated 13000 pregnant women living HIV needing ART for PMTCT in
2011, 1311(13%) received it; a slight scale up was observed in 2012 when out 12000
pregnant women in need of ART for PMTCT 1680 (14%) received it (83). In Chad, the
ministry of health still adopts the former WHO Option B regimen (initiation of ART to all
pregnant women living with HIV, lifelong if treatment-eligible, or through the end of the
mother-to-child transmission risk period if not eligible for treatment) the latest guidelines
were established in Mai 2011 (94).
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Chapter III: Methods

Study design and setting

This was a retrospective cross-sectional study, in which we did a quantitative, and
secondary analysis of data. We used data obtained from the Demographic and Health
Survey (DHS) for Chad and Cameroon: Chad DHS-2014-15, and Cameroon DHS-2011.
DHS data are available from the DHS website (https:// dhsprogram.com/). DHS surveys
are designed to be nationally representative as well as at the first administrative levels;
but not at the subnational levels. Data was collected by DHS in Chad and Cameroon
among men aged 15-59 years old, the questionnaire included modules on HIV
knowledge, sexual behavior, condom use, HIV testing, sociodemographic information,
and STIs.

Sample collection

In each country, a stratified multi-stage cluster sample design was conducted in urban
and rural areas. The sample size was 5248 in chad and 7191 in Cameroon. Data was
collected in Chad from October 2014 to April 2015; in Cameroon from January to August
2011. Participants were asked whether they have ever been tested for HIV, used condom
during sex with last partner, the total number of life time sexual partners, the number of
sexual partner excluding wife during the last 12 months, their educational level, their
wealth index, their marital status, and history of STIs. The possible answers for some
categorical variables were “No”, “Yes”, and “Don’t know”.
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Description of variables
Our two dependent variables were “ever been tested for HIV”, and “condom use during
last sex with most recent partner”. These variables were dichotomized into “Yes” or “No”
based on the response to the question “have you ever been tested for HIV?”, and “did
you used condom during sex with your most recent partner?” respectively. There were
two missing values for condom use, and were not included in the analysis.
Covariates were grouped into two categories consisting of HIV knowledge and risk factors
(“know a place to get HIV test”, “a healthy-looking person can have HIV”, “ever heard of
HIV”, “have ever paid anyone in exchange for sex”, “had any STI in the last 12 months”,
“had genital sore/ulcer in the last 12 months”, “don’t know any source for condoms”, “total
lifetime number of sex partners”, “number of sex partners excluding spouse in the last 12
months”, “children should be taught about condoms to avoid AIDS”, and “know a place to
get HIV test”), and sociodemographic characteristics included age, educational level,
wealth index, marital status and type of place of residence.
The possible answers to the variable “Educational level” were coded “no education”,
“primary”, “secondary” and “higher”. But we decided to regroup the participants into
“primary or less”, “secondary”, and “higher”. Wealth index was coded as “poorest”,
“poorer”, “middle”, “richer”, and “richest”; we decided to regroup these answers into
“lower” (for poorest and poorer), “middle” (for middle), and “upper” (for richer and richest).
Marital status was coded as “never in union”, “married”, “living with partner”, “widowed”,
“divorced”, and “no longer living together/separated”; we reorganized the respondents
into “never in union”, “married/living with partner”, “divorced/widowed/separated”.
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Continuous variables were categorized and proportions were compared using a chisquared test.

Statistical analysis

In the first part of the analysis we computed the proportions of the sociodemographic
characteristics and the distribution of HIV knowledge and risk factors in both countries for
comparison, and the difference in the data (Chad-Cameroon) was noted (table 1 and 2).
In the second part of the analysis we fitted a separate multilevel logistic model for each
country for the outcome variable “Ever been tested for HIV” and “condom used during last
sex with most recent partner”. The two explanatory variables were used in interaction with
sociodemographic covariates and HIV knowledge and risk factors covariates. The
Estimated Odds Ratios (EOR) were obtained from the logistic regression models, and the
95% confidence interval. Chi-square was used for p-values (tables 3, 4, 5, and 6).
Finally, we conducted a separated multivariate analysis with the two outcomes variable
in each country looking for interaction between knowing a place to get HIV tes t and ever
tested for HIV. In this multivariate logistic regression, we controlled for the variable age,
wealth index, marital status, educational level and place of residence (table 7). The last
multivariate logistic regression model looked at the interaction between knowing a source
of condom and condom use. For this model, we adjusted for the variables age, wealth
index, marital status, educational level, and place of residence.
All statistical analyses were performed using Statistical Analysis System software, SAS®
9.4 for window. A P-value of less than 0.05 was considered statistically significant.
Microsoft Excel was used to display tables and graphs.
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Ethics
Prior to this survey the DHS questionnaires and procedure have been reviewed and
approved by the by the ICF International Institutional Review Board (IRB), and by each
host country IRB. Before each interview, an informed consent statement is read to the
participant,

who

may

accept

or

decline

to

participate

(See

more

at:

http://dhsprogram.com/). The ICF International IRB procedure complies with the U.S.
Department of Health and Human Services regulations for the protection of human
subjects (45 CFR 46). In Addition, we submitted a research application to the Georgia
State University Review Board and we obtained an IRB waiver (IRB Number: H17467,
Reference Number: 343492).
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Chapter IV: Results

Sociodemographic characteristic of the participants
In Chad, 5248 participants were included in the study, whereas in Cameroon the sample
size was 7191. The median age of respondents was 30 (IQR, 20-40) years in Chad, and
28 (IQR, 20-40) in Cameroon. Most of the participants (70.05%) in Chad had only primary
education or none, in Cameroon 42.46% never attended school or had only primary
educational level. Almost half of the participants (49.58%) in Cameroon lived in rural
areas, whereas majority (71.1%) of Chadians lived in rural areas. Majority of participants
(60.65%) in Chad were married or living with partner; in Cameroon 50.55% were married
or living with partner. The wealth index was similar in both countries, at all levels as shown
in table 1.

HIV Knowledge and risk factors distribution among participants
HIV testing was very low in Chad, only 12.45% reported had ever been tested for HIV, in
Cameroon 41.77% had been tested before. In Chad, 46.40% of participants did not know
a place to get HIV test, whereas 11.15% did not know where to get a test. The median
number of lifetime sexual partners was 2 (IQR, 1-4) in Chad, and 6 (IQR, 3-15) in
Cameroon. Among Chadian participants 31.63% had only one lifetime sexual partner,
10.76% Cameroon had only one lifetime sex partner. In Chad 86.95% of participants
reported having no sex partner other than their spouse in the last 12 months; in
Cameroon, the proportion was 57.3%. Among the respondents in Chad and Cameroon,
6.65% and 32.53% respectively reported using condom during last sex with most recent

34 | P a g e B o n h e u r D o u n e b a i n e t h e s i s

partner; 54.49% and 11.85% of participants respectively in Chad and Cameroon did not
know any source for condoms. The proportion of people who reported having ever paid
anyone in exchange for sex was respectively 9.33% and 4.96% in chad and Cameroon.
Only 1.11% of Chadians have had a STI in the last 12 months, the proportion was 3.98%
in Cameroon. Among respondents in Chad,18.05% never heard of AIDS whereas in
Cameroon the proportion was 1.63%. Respectively, 17% and 10.36% of participants in
Chad and Cameroon believed that a healthy-looking person cannot have HIV; 41.48%
and 27.02% in Chad and Cameroon considered that children should be taught about
condoms to avoid HIV. Table 2 shows the details of the distribution.

Bivariate

association

between

Condom

use

and

the

Sociodemographic

characteristics
As shown on the table 3, in Chad, the age group 20-24 years old had the highest condom
use during last sex with most recent partner (2.55%), with an estimated odds ratio (EOR)
of 0.79 (0.54, 1.2). In Cameroon, the highest rate of condom use with most recent partner
was observed among the age group 25-34 years (10.37%) with an EOR of 0.24 (0.19,
0.29). In both countries participants with upper level of wealth index had the highest rate
of condom use with most recent partner, 5.24% with an EOR of 5.46(3.71, 8.04) in Chad;
and 21.13% with an EOR of 4.43(3.82. 5.14). There was significant difference between
those that reported “Yes” and “No” (P value <0.001) among this group in both countries.
People that reported never been in union in both countries had the highest rate of condom
use with most recent partner (4.89% in Chad, and 21.31% in Cameroon). Urban
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respondents in both countries used more condom with their most recent partner
compared to people living in the rural areas (4.67% in Chad and 21.96% in Cameroon).

Bivariate association between Condom use and HIV risk factors
Condon use during last sex with most recent partner was highest among participants who
reported having 2-5 lifetime sexual partners in both Chad and Cameroon, (3.21% and
12.76% respectively) with EOR of 2.13 (1.45, 3.15) and 1.25 (1.02, 1.55) respectively.
Among those that ever heard of AIDS, 6.49% used condom during last sex with most
recent partner in Chad with an EOR of 6.5 (2.87, 14.68). In Cameroon 32.5% (EOR
4.85(1.73, 13.56)) of participants who ever heard of AIDS, used condom with most recent
partner, and there was statistically significant difference between those who responded
“Yes” and “No” to condom use with most recent partner (P value 0.0026). Condom use
with most recent partner was low among Chadians who reported ever paid anyone in
exchange for sex (1.95% with EOR 5.06 (3.73, 6.87)). In Cameroon 2.49% of those who
used condom with last partner responded having ever paid someone for sex with an EOR
of 2.19(1.7, 2.8). The detail of bivariate associations is shown in the table 4.

Bivariate association between HIV test and sociodemographic characteristics
The table 5 shows that the proportion of people who reported ever tested for HIV
increased with age in both countries. The highest rate of HIV test was in age group ≥ 35
years (5.49% with EOR 6.32(4.33, 9.22) in Chad, and 17.87% with EOR 6.02 (5.14, 7.06)
in Cameroon). The lowest rate of ever been tested for HIV was observed among
individuals with highest educational level in both countries (2.04% with EOR 28.14 (20.05,

36 | P a g e B o n h e u r D o u n e b a i n e t h e s i s

39.5) in Chad), and 6.56% with an EOR 11,8(9.44, 14.77) in Cameroon). The highest
proportion of people who reported ever been tested was observed among individuals with
wealth index of upper level in both countries (8.6% with EOR 2.74 (2.23, 3.37) in Chad,
and 25.87% EOR 4.37(3.89, 4.9) in Cameroon). Chadian and Cameroonians who were
married or living with partner had highest HIV test, respectively 8.08% with EOR
1.41(1.18, 1.7) and 25.94% EOR 2.44 (2.2, 2.69). More people had ever received HIV
test among urban than rural residents; 7.53% and 26.16% among urban resident in Chad
and Cameroon respectively.

Bivariate association between HIV test and HIV risk factors
As shown in table 6, 15.2% of respondents who had ever been tested for HIV knew a
place to get HIV test in Chad, whereas, in Cameroon the proportion was 42.49%. The
proportion of people who have ever been tested for HIV was highest among individuals
with 2-5 total lifetime sexual partners; 7.20% in Chad, with EOR of 2.14 (1.68, 2.74), In
Cameroon the proportion was highest among respondents with 10 or more lifetime sex
partners, 22.76% with EOR 5.02 (4.1, 6.15). There was low HIV testing among people
who reported having an STI in the last 12 months (0.36%) in Chad; In Cameroon, the
proportion was 2.23% (EOR 1.83 (1.45, 2.33)). In Chad 12.45% of those who ever heard
of AIDS had been tested at least once; the proportion is 41.79% in Cameroon. The
proportion of HIV testing is low among people who reported ever paid for sex in both
countries; 3.29% with EOR 3.52(2.79, 4.45) among Chadians; and 2.45% with EOR of
1.04 (0.81, 1.32) among Cameroonians.
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Multivariate logistic regression: interaction between knowing a source of condom
and condom use.
After controlling for confounding variables such as age, wealth index educational level
and the place of residence, the adjusted odds ratio of interaction between knowing a
source of condom and condom use was 0.17(0.1, 0.3) in Chad and 0.1(0.06, 0.17) in
Cameroon.
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Table 1: Sociodemographic distribution of Chadian and Cameroonian Men, Demographic
and Health Survey (Chad DHS 2014-15, and Cameroon DHS 2011)

Population, N
Age in year (median, IQR)
Educational level
primary or less
Secondary
Higher
Wealth index
Lower
Middle
Upper
marital status
never in union
married/living with partner
Div/wid/sep
Type of place of residence
Urban
Rural

Chad
N (%)
5248 (100)
30(20, 40)
5248
3676 (70.05)
1400(26.68)
172(3.28)
5248
1704 (32.47)
1099 (20.94)
2445 (46.59)
5248
1926 (36.70)
3183 (60.65)
139 (2.65)
5248
1515(28.87)
3733(71.13)

Cameroon
N (%)
7191 (100)
28(20, 40)
7191
3053 (42.46)
3558(49.48)
580(8.07)
7191
2419 (33.64)
1474 (20.50)
3298 (45.86)
7191
3187(44.32)
3635 (50.55)
369 (5.13)
7191
3626(50.42)
3565(49.58)

Difference: Quantitative difference between Chad and Cameroon data
Div/wid/sep: Divorced, widowed or separated
IQR: Interquartile range
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Difference

2
27.59
-22.8
-4.79
-1.17
0.44
0.73
-7.62
10.1
-2.48
-21.55
21.55

Table 2: Distribution of HIV knowledge and risk factors among Chadian and Cameroonian
men, Demographic and Health Survey (Chad DHS 2014-15, and Cameroon DHS 2011)
Population, N
Ever been tested for HIV, N (%)
No
Yes
Know a place to get HIV test
No
Yes
Total lifetime number of sex partners
1
2–5
6–9
>=10
median, IQR
Number of sex partners, excluding spouse, in last 12
months
0
1
2–5
6–9
>=10
Condom used during last sex with most recent partner
No
Yes
Don't know any source for condoms
No (source known)
Yes (no source known)
Children should be taught about condoms to avoid AIDS
No
Yes
Don't know/ depends
Heard about other STIs
No
Yes
Had genital sore/ulcer in last 12 months
No
Yes
Don't know
Had any STI in last 12 months
No
Yes
Don't know
Ever heard of AIDS
No
Yes
A healthy-looking person can have HIV
No
Yes
Don't know
Have ever paid anyone in exchange for sex
No
Yes

Chad
N (%)
5248 (100)
5246
4593(87.55)
653(12.45)
4297
1994(46.40)
2303(53.60)
4000
1265 (31.63)
2005 (50.13)
316 (7.90)
414 (10.35)
2(1, 4)
5233

Cameroon
N (%)
7191 (100)
7191
4187(58.23)
3004(41.77)
7070
788(11.15)
6282(88.85)
5992
645 (10.76)
2128 (35.51)
951 (15.87)
2268 (37.85)
6(3, 15)
7171

Difference

4550 (86.95)
588 (11.24)
85 (1.62)
3 (0.06)
7 (0.13)
3684
3439(93.35)
245(6.65)
5219
2375(45.51)
2844(54.49)
4229
1754(41.48)
1913(45.24)
562(13.29)
5130
2083(40.60)
3047(59.40)
5205
5156(99.06)
34(0.65)
15(0.29)
5221
5158(98.79)
58(1.11)
5(0.10)
5246
947(18.05)
4299(81.95)
4240
721(17.00)
2379(56.11)
1140(26.89)
3954
3585(90.67)
369(9.33)

4109(57.30)
1966(27.42)
963 (13.43)
77 (1.07)
56(0.78)
5533
3733(67.47)
1800(32.53)
7150
6303(88.15)
847(11.85)
7036
1901(27.02)
4887(69.46)
248(3.52)
7146
833(11.66)
6313(88.34)
7180
6958(96.91)
212(2.95)
10(0.14)
7164
6868(95.87)
285(3.98)
11(0.15)
7189
117 (1.63)
7072(98.37)
7056
731(10.36)
6004(85.09)
321(4.55)
5501
5228 (95.04)
273(4.96)

29.65
-16.18
-11.81
-1.01
-0.65

Difference: Quantitative difference between Chad and Cameroon data
IQR: interquartile range
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29.32
-29.32
35.25
-35.25
20.87
14.62
-7.97
-27.5
-4

25.88
-25.88
-42.64
42.64
14.46
-24.22
9.77
28.94
-28.94
2.15
-2.3
0.15
2.92
-2.87
-0.05
16.42
-16.42
6.64
-28.98
22.34
-4.37
4.37

Table 3: Bivariate association between condom use and sociodemographic characteristic
of Chad and Cameroonian men, (Chad DHS 2014-15, Cameroon DHS 2011)

AGE group
15-19
20-24
25-34
>=35
Educational level
primary or less
Secondary
Higher
Wealth index
Lower
Middle
Upper
marital status
never in union
married/with partner
div/wid/sep
Type of place of
residence
Urban
Rural

Condom used during last sex with most recent partner
Chad
Cameroon
EOR (CI)
P
No
Yes
EOR (CI)
Value*
N=3733
N= 1800
(67.47)
(32.53)

No
N=3438
(93.35%)

Yes
N=245
(6.65%)

143 (3.88)
331 (8.98)
1051 (28.53)
1914 (51.95)

51 (1.38)
94 (2.55)
75 (2.04)
25 (0.68)

1
0.79(0.54, 1.2)
0.2 (0.14, 0.3)
0.04 (0.02, 0.06)

<.0001
0.0047
<.0001

178 (3.22)
356 (6.43)
1130 (20.42)
2069 (37.39)

380 (6.87)
528 (9.54)
574 (10.37)
318 (5.75)

1
0.69(0.55, 0.87)
0.24(0.19, 0.29)
0.07 (0.06, 0.08)

<.0001
<.0001
<.0001

2617 (71.04)
717 (19.46)
105 (2.85)

45 (1.22)
165 (4.48)
35 (0.95)

1
13.38 (9.53, 18.8)
19.4(11.96, 31.42)

<.0001
<.0001

1928 (34.85)
1550 (28.01)
255 (4.61)

447 (8.08)
1107 (20.01)
246 (4.45)

1
3.08 (2.7, 3.5)
4.16 (3.4, 5.01)

<.0001
<.0001

1260 (34.20)
742 (20.14)
1437 (39.01)

31 (0.84)
21 (0.57)
193 (5.24)

1
1.15 (0.65, 2.02)
5.46(3.71, 8.04)

0.0034
<.0001

1534 (27.72)
779 (14.08)
1420 (25.66)

285 (5.15)
346 (6.25)
1169 (21.13)

1
2.391 (2.0, 2.86)
4.43 (3.82, 5.14)

0.0892
<.0001

331 (8.98)
3054 (82.90)
54 (1.47)

180 (4.89)
52 (1.41)
13 (0.35)

1
0.03(0.02, 0.04)
0.44 (0.24, 0.83)

<.0001
0.0042

516 (9.33)
3023 (54.64)
194 (3.51)

1179 (21.31)
505 (9.13)
116 (2.10)

1
0.07(0.06, 0.08)
0.26 (0.20, 0.34)

<.0001
0.7895

803 (21.80)
2636 (71.55)

172 (4.67)
73 (1.98)

1
0.13 (0.01, 0.17)

<.0001

1559 (28.18)
2174 (39.29)

1215 (21.96)
585 (10.57)

1
0.34 (0.30, 0.38)

<.0001

EOR: Estimated Odds Ratio
CI:95% Confidence Interval
Div/wid/sep: Divorced, widowed or separated
*: chi-square
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p
value*

Table 4: Bivariate association between condom use and HIV risk factors among Chadian
and Cameroonian men (Chad DHS 2014-15, Cameroon DHS 2011)

Total lifetime number of
sex partners
1
2–5
6–9
10+
Number of sex partners,
excluding spouse, in last
12 months
0
1
2–5
6- 9
>=10
Had any STI in last 12
months
No
Yes
Don't know
Ever heard of AIDS
No
Yes
Have ever paid anyone in
exchange for sex
No
Yes

Condom used during last sex with most recent partner
Chad
Cameroon
EOR
p
No
Yes
EOR
value*
N=3733
N=1800
(67.47)
(32.53)

No
N=3438
(93.35%)

Yes
N= 245
(6.65%)

1083 (29.45)
1763 (47.93)
274 (7.45)
313 (8.51)

34 (0.92)
118 (3.21)
27 (0.73)
66 (1.79)

1
2.13 (1.45, 3.15)
3.14 (1.86, 5.3)
6.72 (4.36, 10.35)

0.06
0.237
<.0001

333 (6.03)
1220 (22.11)
607 (11)
1561 (28.28)

153 (2.77)
704 (12.76)
296 (5.36)
645 (11.69)

1
1.25 (1.02, 1.55)
1.06(0.84, 1.35)
0.9 (0.73, 1.11)

0.0001
0.8153
0.0015

2967 (80.63)
421 (11.44)
43 (1.17)
0(0)
4 (0.11)

32 (0.87)
165 (4.48)
42 (1.14)
3 (0.08)
3 (0.08)

1
36.34 (24.5, 53.79)
90.56 (52.27, 156.92)
***
69.54 (14.95, 323.38)

0.9705
0.9822
0.964
0.9788

2263 (40.95)
989 (17.90)
412 (7.46)
39 (0.71)
24 (0.43)

204 (3.69)
974 (17.63)
551 (9.97)
38 (0.69)
32 (0.58)

1
10.92 (9.23, 12.93)
14.84(12.24, 18)
10.8 (6.76, 17.28)
14.8(8.55, 25.6)

<.0001
<.0001
0.0691
0.0029

3369 (92.02)
46 (1.26)
3 (0.08)

233 (6.36)
9 (0.25)
1 (0.03)

1
2.83 (1.37, 5.85)
4.82 (0.5, 46.52)

0.7107
0.368

3529 (64.05)
182 (3.30)
7 (0.13)

1695 (30.8)
95 (1.72)
2 (0.04)

1
1.09 (0.84, 1.4)
0.6(0.12, 2.87)

0.4154
0.486

482 (13.09)
2955 (80.26)

6 (0.16)
239 (6.49)

1
6.5 (2.87, 14.68)

<.0001

40 (0.72)
3691 (66.73)

4 (0.07)
1796 (32.5)

1
4.85 (1.73, 13.56)

0.0026

3130 (86.18)
266 (7.32)

165 (4.54)
71 (1.95)

1
5.06 (3.73, 6.87)

<.0001

3577 (65.05)
136 (2.47)

1649 (30)
137 (2.49)

1
2.19 (1.7, 2.8)

<.0001

EOR: Estimated Odds Ratio
CI:95% Confidence Interval
*: chi-square
***: >999.999 (<0.001, >999.999)
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p
value*

Table 5: Bivariate association between HIV test and sociodemographic characteristics
of Chadian and Cameroonian men, (Chad DHS 2014-15, Cameroon DHS 2011)

Ever been tested for HIV

AGE group
15-19
20-24
25-34
>=35
Educational level
primary or less
secondary
higher
Wealth index
Lower
middle
upper
marital status
never in union
married/with part
div/wid/sep
Type of place of
residence
Urban
Rural

Chad
EOR (95% CI)

No
N=4187
(58.23)

Cameroon
Yes
EOR (95% CI)
N=3004
(41.77)

1377(19.15)
717(9.97)
843 (11.72)
1250(17.38)

235(3.27)
474(6.59)
1010(14.05)
1285 (17.87)

1
3.88 (3.23, 4.64)
7.02(5.95, 8.28)
6.02 (5.14, 7.06)

0.1133
<.0001
<.0001

0.6646
<.0001

2228(30.98)
1851(25.74)
108 (1.50)

825(11.47)
1707(23.74)
472(6.56)

1
2.5 (2.25, 2.77)
11.8 (9.44, 14.77)

<.0001
<.0001

1
0.85 (0.6, 1.15)

<.0001

1866 (25.95)
883 (12.28)

553 (7.69)
591 (8.22)

1
2.26(1.2, 2.6)

0.2013

451 (8.60)

2.74 (2.23, 3.37)

<.0001

1438 (20)

1860 (25.87)

4.37(3.89, 4.9)

<.0001

1735(33.07)
2759 (52.59)
99 (1.89)

189(3.60)
424 (8.08)
40 (0.76)

1
1.41 (1.18, 1.7)
3.71(2.5, 5.52)

0.0062
<.0001

2224(30.93)
1770 (24.61)
193 (2.68)

963(13.39)
1865 (25.94)
176 (2.45)

1
2.44 (2.2, 2.69)
2.1 (1.7, 2.62)

<.0001
0.0052

1119(21.33)
3474(66.22)

395(7.53)
258(4.92)

1
0.21 (0.18, 0.25)

<.0001

1745(24.27)
2442(33.96)

1881(26.16)
1123(15.62)

1
0.427 (0.39, 0.5)

<.0001

No
N=4593
(87.55%)

Yes
N=653
(12.45%)

1191(22.70)
624(11.89)
1027 (19.58)
1751 (33.38)

31(0.59)
111(2.12)
223 (4.25)
288 (5.49)

1
6.84 (4.54, 10.3)
8.34(5.68, 12.26)
6.32(4.33, 9.22)

3472 (66.18)
1056 (20.13)
65 (1.24)

203 (3.87)
343 (6.54)
107 (2.04)

1
5.56(4.6, 6.7)
28.14(20.05, 39.5)

1574 (30)
1026 (19.56)

130 (2.48)
72 (1.37)

1993 (37.99)

P value

EOR: Estimated Odds Ratio
CI:95% Confidence Interval
*: chi-square
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p value

Table 6: Bivariate association between HIV test and HIV risk factors among Chadian
and Cameroonian men, (Chad DHS 2014-15, Cameroon DHS 2011)
Ever been tested for HIV

Know a place to get HIV
test
No
Yes
Total lifetime number of
sex partners
1
2–5
6- 9
10+
Number of sex partners,
excluding spouse, in last
12 months
0
1
2–5
6- 9
>=10
Had any STI in last 12
months
No
Yes
Don't know
Ever heard of AIDS
No
Yes
Have ever paid anyone
in exchange for sex
No
Yes

Chad
EOR (95% CI)

No
N=4187
(58.23)

Cameroon
Yes
N=3004
(41.77)

0.925

788(11.15)
3278(46.36)

1
2.14 (1.68, 2.74)
4.04 (2.89, 5.64)
8.62 (6.45, 11.5)

<.0001
0.003
<.0001

467(8.93)
141(2.70)
34 (0.65)
3 (0.06)
3 (0.06)

1
2.77 (2.24, 3.42)
5.83(3.74, 9.09)
***
6.56 (1.47, 29.4)

4523(86.66)
39(0.75)
5(0.10)

633(12.13)
19(0.36)
0(0)

947(18.06)
3644(69.49)

3103(78.52)
239(6.05)

EOR (95% CI)

p value*

0(0)
3004(42.49)

1
***

0.931

496(8.28)
1253 (20.91)
476 (7.94)
904 (15.09)

149(2.49)
875 (14.60)
475 (7.93)
1364 (22.76)

1
2.33 (1.9, 2.85)
3.32(2.66, 4.15)
5.02 (4.1, 6.15)

0.114
<.0001
<.0001

0.955
0.967
0.958
0.969

2663(37.14)
999(13.93)
460 (6.41)
31 (0.43)
22 (0.31)

1446(20.16)
967(13.48)
503 (7.01)
46 (0.64)
34 (0.47)

1
1.79 (1.6, 2)
2.01 (1.75, 2.32)
2.74 (1.73, 4.33)
2.85 (1.66, 4.89)

0.282
0.702
0.081
0.09

1
3.5 (2, 6.06)
**

0.966
0.971

4042(56.42)
125(1.74)
6(0.08)

2826(39.45)
160(2.23)
5(0.07)

1
1.83 (1.45, 2.33)
1.19 (0.36, 3.91)

0.112
0.835

0(0)
653(12.45)

1
***

0.954

117(1.63)
4068(56.59)

0(0)
3004(41.79)

1
***

0.937

480(12.15)
130(3.29)

1
3.52 (2.79, 4.45)

<.0001

2687(48.85)
138(2.51)

2541(46.19)
135(2.45)

1
1.04 (0.81, 1.32)

0.785

No
N=4593
(87.55%)

Yes
N=653
(12.45%)

1994(46.42)
1649(38.38)

0(0%)
653(15.20)

1
***

1172(29.31)
1716 (42.92)
240 (6.00)
247 (6.18)

92(2.30)
288 (7.20)
76 (1.90)
167 (4.18)

4082(78.03)
446(8.53)
51 (0.97)
0(0%)
4 (0.08)

P
value*

EOR: Estimated Odds Ratio
CI:95% Confidence Interval
*: chi-square
***: >999.999 (<0.001, >999.999)
***: <0.001 (<0.001, >999.999)
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Table 7: Interaction between knowing a source of condom and condom use
Condom use
Variable

Chad
AOR

Cameroon
AOR

Don't know any source for condoms
No (source known)
1
1
Yes (no source known)
0.17 (0.10, 0.3)
0.1(0.06, 0.17)
Age
0.38(0.33, 0.44)
0.39(0.36, 0.42)
Wealth index
1.55(1.2, 1.99)
1.53(1.36, 1.71)
education level
2.49(1.93, 3.2)
1.44(1.3, 1.61)
place of residence
0.45(0.23, 0.68)
0.74(0.61, 0.89)
Multivariate logistic regression, adjusted for Age, Wealth index, educational level, and place of
residence.
AOR: Adjusted Odds Ratio
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Chapter V: Discussion and Conclusion

Sociodemographic characteristic of the participants
We observed that the age distribution is similar in Chad and Cameroon. However, there
was significant difference in educational level among participants in these countries; with
very low level in Chad where 70.05% of the respondents had only primary education or
none, compared to 42.46% in Cameroon. This difference is also shown in the human
development index report 2015 (15) of adult literacy rate. Cameroonian men were equally
distributed in rural and urban areas, whereas majority of Chadian men lived in the rural
areas (71.1%), even though wealth index was similar in both countries, at all levels.

HIV Knowledge and risk factors distribution among participants
We found that very high percentage (46.40%) of Chadian men did not know where to get
the HIV test, resulting in very low HIV testing, only 12.45% reported having ever been
tested. This could be explained by the fact that in Chad majority of testing centers are in
the cities, however, most Chadian (71.1%) live in the rural areas; in addition, majority of
testing centers are linked to ANC activities and PMTCT program which does not include
men yet. Nonetheless, previous national surveys have shown even lower proportion
(7.04%) of HIV testing among men in Chad (95). These results in Chad are substantially
different from the finding in Cameroon where 11.15% did not know a place to get the HIV
test, and the proportion of ever testing for HIV was 41.77%.
On the other hand, this survey shows that Chadian men have lower number of lifetime
sexual partner, the median was 2 (IQR, 1-4) comparing to Cameroonian, the median of 6
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(IQR 3-15) and substantial proportion of Chadian men (86.96%) reported being faithful to
their wives whereas 57.30% of Cameroonian were loyal to their partners in the last 12
months. This difference could be partially explained by the even distribution of
Cameroonians in the rural and urban areas, and the difference in tradition and culture
among the communities.
Majority of Chadian men did not know a source for condoms (54.49%) thus, very few
reported using condom during last sex with most recent partner (6.65%), whereas in
Cameroon 11.85% did not know a source for condoms, and 32.53% had a protected sex
with most recent partners. This substantial difference might be attributed to the fact that
Chadian population is a more traditional society where discussion about condom and sex
is still taboo. In addition, this survey shows that 41.48% of Chadian participants believed
that children should not be taught about condoms to avoid AIDS; whereas 27,02% of
Cameroonians were opposed to children’s education about condoms.
In general Cameroonian men were more knowledgeable about HIV than Chadian men;
98.37% of them heard of AIDS before, and 85.09% reported that a healthy-looking person
can have HIV; whereas 81.95% of Chadian had ever heard of AIDS before and only
56.11% believe that a healthy-looking person could be HIV seropositive. This results
show that there is need for more emphasis on HIV communication and educ ation among
Chadian men, which will substantially reduce the present prevalence and incidence of the
infection among the communities.

Bivariate

association

between

Condom

characteristics
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use

and

the

Sociodemographic

Condom use with most recent partner was low among all age groups; the lowest rates
were observed among age group ≥35 years old in both countries. This age group is
associated with marriage, which is inversely associated with condom use with last partner
in this survey. The highest rate of condom use was observed among men that reported
never been in union in both countries but still substantially low in Chad. Condom use was
more observed among urban than rural resident in both countries. The proportion was
very low among rural respondents in Chad. This shows that condom distribution program
should target also rural areas where important number of communities are exposed to
HIV in both countries with more emphasis on Chad. Most wealthy people in both countries
had highest condom use with last partner, probably because of their correlation with urban
residencies where access to condom is easier comparing to provinces.

Bivariate association between Condom use and HIV risk factors
Among Chadian participants the odds of condom use increases with the number of
lifetime sexual partners. This could be explained by the fact that people with multiple
sexual partners use condom mainly with another partner than their wife. Unlike in Chad
the odds of condom use with last partner did not increase with number of life time sexual
partner in Cameroon, where the lowest odds (0.9(0.73, 1.11)) were observed among
people with 10 or more lifetime sexual partners.
Our results also show that the odds of condom use with last partner were higher among
Chadian men comparing to Cameroonians, although the proportion of condom use were
higher among Cameroonian.

This could justify the fact that condom use could be

improved in Chad if condom were distributed evenly in the regions. However, it should be
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stressed that both countries need emphasis on condom use among communities,
especially for men with multiple sexual partners.
We found that Chadian men were more likely to engage in compensation in exchange for
sex than Cameroonian men and small percentage of them used condom, the odds of
condom use were (5.06 (3.73, 6.87)) for Chadian and (2.19(1.17, 2.8)) among
Cameroonians of this group. These findings might be the result of inconsistent availability
of condoms where sex workers are employed in Chad.

Bivariate association between HIV test and sociodemographic characteristics
HIV testing increased with age group in both countries, the highest testing was observed
among the age group ≥35 years old. However, previous studies showed that youngers
people are more at risk (7). Therefore, screening and testing activities in both countries
should target more adolescents and young adults.
We also found that Condom use during last sex with most recent partner was strongly
and positively associated with education level, people with higher education are likely to
get HIV testing than individuals with secondary and primary education in both countries,
however, this group represent an insignificant proportion of the population. Testing
activities should also target people of lower education level.
There was also strong association between ever been test for HIV and upper level of
wealth index in Chad (EOR 2.74(2.23, 3.37)) and in Cameroon (EOR 4.37(3.89, 4.9)).
This correlate with the fact that wealthy people in these countries are more likely to be
aged more than 35 years, and educated.
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Rural residency was inversely associated with ever been tested for HIV in both countries
(EOR 0.21 (0.18, 0.25) in Chad and EOR of 0.42 (0.39, 0.5) in Cameroon).

Bivariate association between HIV test and HIV risk factors
Knowing a place to get HIV test was extremely positively associated with ever been tested
in both countries. Perhaps, the low testing rate in Chad could be attributed to the lack of
information about testing facilities in the regions. The odds of ever being tested for HIV
among participants increased with the number of lifetime sexual partners in both
countries. And there was strong positive association between having ever paying anyone
in exchange for sex and ever being tested for HIV, among Chadian EOR 3.52(2.79, 4.45).

Multivariate logistic regression
After controlling for potential confounding factors such as age, wealth index, educational
level, place of residency, there was strong and positive association between knowing a
place to get HIV test and ever being tested for HIV in both countries. However, after
controlling for all these variables there was inverse association between knowing a source
of condom and condom use in both countries. (AOR 0.17(0.1, 0.3) in Chad and 0.1(0.06,
0.17) in Cameroon).

Strengths and limitations
Our study has several limitations, first as the data was collected from a survey, we
conducted a cross sectional study from which we could not make a causal inference about
our findings. Second, this survey was a self-reported sexual behavior in the communities
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where open discussion about sex is still taboo, therefore is difficult to eliminate some
biases such as under reporting and over reporting. Third, we did a comparative analysis
between two neighboring countries; although data collection in both countries were done
by the DHS and used the same methodology, however, the surveys were not conducted
in the same period. In Chad, the survey was conducted in 2014-15, and in Cameroon in
2011, and therefore, it is possible that the findings might have changed little bit in
Cameroon since 2011. Finally, in this study we defined our outcome variable as condom
use during last sex with most recent partner. This does not allow us to capture the overall
consistent and correct use of condom in the two countries.
Nonetheless, despite these limitations, our study used a DHS data which has a very good
representativeness at the national and regional levels. Surveys were conducted in all the
regions in both countries.
Implication for public health policies
Our study has several implications for health policies, first, our findings suggest that there
is crucial need to emphasize on HIV testing and screening among Chadian men, in the
rural as well as in the urban areas. In addition, we found that HIV knowledge was very
low among Chadian men, and low rate of condom use. The ministry of health and its
partners should therefore focus more on HIV literacy among communities in Chad; not
only in the cities but also in the regions where majority of people live. Also, the HIV
prevention program in Chad should find a practical way to improve the poor rate of
condom use which would decrease the HIV incidence.
In Cameroon, although there is also need to improve the rate of condom use and HIV
testing, however, the main and dominant risk factor was multiple sexual partners.

51 | P a g e B o n h e u r D o u n e b a i n e t h e s i s

Previous program in Uganda known as “zero-grazing” aiming at reducing multiple sexual
partners, and concurrency among populations have shown to be very effective and was
correlated with HIV reduction among communities (96).

Conclusion
Condom use and HIV testing rates were very low among Chadian men comparing to
Cameroonian men; and were positively associated with educational level and wealth
index in both countries. However, Cameroonian men were more likely to engage in
multiple sexual partners and extra-marital relationship than Chadian men. Although HIV
knowledge was higher among respondents in Cameroon than those in Chad, STIs were
observed more frequently among Cameroonian than Chadian men.
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